Pharmacy

The FINANCIAL -- Gilead Sciences, Inc. on February 7 announced that the U.S. Food and Drug Administration (FDA) has approved...

The FINANCIAL -- Gilead Sciences, Inc. announced on February 6 its results of operations for the fourth quarter and full...

The FINANCIAL -- Bristol-Myers Squibb Company on February 5 reported results for the fourth quarter and full year of 2017,...

The FINANCIAL -- Amgen on February 1 announced financial results for the fourth quarter and full year 2017. Key results...

The FINANCIAL -- Merck known as MSD outside the United States and Canada, on February 2 announced financial results for...

The FINANCIAL -- Sales within biopharmaceuticals declined by 18% to DKK 18.8 billion (16% in local currencies), reflecting the impact...

The FINANCIAL -- Commenting on the Group’s results, Roche CEO Severin Schwan said: “In 2017, we made significant progress with...

The FINANCIAL -- Eli Lilly and Company on January 31 announced financial results for the fourth quarter and full year...

The FINANCIAL -- WHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number...

The FINANCIAL -- Sanofi and Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies, entered into a...

The FINANCIAL -- AbbVie announced financial results for the fourth quarter ended December 31, 2017.

The FINANCIAL -- America's influenza epidemic is at its peak, making it especially important for optometric practices to take extra...

The FINANCIAL -- Abbott on January 24 announced financial results for the fourth quarter ended Dec. 31, 2017.

The FINANCIAL -- Johnson & Johnson on January 23 announced sales of $20.2 billion for the fourth quarter of 2017,...

The FINANCIAL -- Bristol-Myers Squibb Company announced on Januray 22 that the European Commission (EC) has expanded the indication of...